Primary vesicoureteral reflux [Primärer vesikoureteraler Reflux]

被引:0
|
作者
Stein R. [1 ]
Ziesel C. [1 ]
Rubenwolf P. [1 ]
Beetz R. [2 ]
机构
[1] Abteilung Kinderurologie der Urologischen Klinik und Poliklinik, Universitätsmedizin Mainz, Johannes Gutenberg-Universität Mainz, Langenbeck Straße 1
[2] Zentrum für Kinder- und Jugendmedizin, Universitätsmedizin Mainz, Johannes Gutenberg-Universität Mainz, Mainz
来源
Der Urologe | 2013年 / 52卷 / 1期
关键词
Dysfunctional elimination syndrome; Endoscopic therapy; Prophylaxis; antibacterial; Reflux; vesicoureteral; Voiding cystourethrography;
D O I
10.1007/s00120-012-3079-z
中图分类号
学科分类号
摘要
The never ending discussion about the diagnostics and treatment of vesicoureteral reflux (VUR) now includes arguments for diagnostic nihilism as well as invasive diagnostics and therapy, which is reminiscent of the debate on prostate cancer in adulthood. The common goal of all currently competing diagnostic strategies and approaches is the prevention of renal scars by the most effective and least burdensome approach. There is a difference between acquired pyelonephritic scars with VUR (acquired reflux nephropathy) and congenital reflux nephropathy (primary dysplasia) which cannot be influenced by any therapy. The VUR can be verified by conventional radiological voiding cystourethrography (VCUG), by urosonography, radionuclide cystography or even by magnetic resonance imaging (MRI). The guidelines of the European Association of Urology/European Society for Paediatric Urology (EAU/ESPU) recommend radiological screening for VUR after the first febrile urinary tract infection. Significant risk factors in patients with VUR are recurrent urinary tract infections (UTI) and parenchymal scarring and the patients should undergo patient and risk-adapted therapy. Infants with dilating reflux have a higher risk of renal scarring than those without dilatation of the renal pelvis. Bladder dysfunction or dysfunctional elimination syndrome represents a well-known but previously neglected risk factor in combination with VUR and should be treated prior to any surgical intervention as far as is possible. Certainly not every patient with VUR needs therapy. The current treatment strategies take into account age and gender, the presence of dysplastic or pyelonephritic renal scars, the clinical symptoms, bladder dysfunction and frequency and severity of recurrent UTI as criteria for the therapy decision. The use of an antibacterial prophylaxis as well as the duration is controversially discussed. Endoscopic therapy can be a good alternative to antibacterial prophylaxis or a surveillance strategy in patients with low grade VUR. In patients with dilating VUR and given indications for surgery, endoscopic treatment can be offered. However, parents should be completely informed about the significantly lower success rate of endoscopic therapy compared to open surgical procedures. The open surgical techniques guarantee the highest success rates and should be used in patients with a dilating VUR and high risk of renal damage. © 2013 Springer-Verlag Berlin Heidelberg.
引用
收藏
页码:39 / 47
页数:8
相关论文
共 50 条
  • [21] Risk of hypertension in primary vesicoureteral reflux
    Ana C. Simoes e Silva
    Jose Maria P. Silva
    Jose Silverio S. Diniz
    Sérgio V. B. Pinheiro
    Eleonora M. Lima
    Mariana A. Vasconcelos
    Mariana R. Pimenta
    Eduardo A. Oliveira
    [J]. Pediatric Nephrology, 2007, 22 : 459 - 462
  • [22] Primary Vesicoureteral Reflux and Renal Scarring
    Mattoo, Tej K.
    Mohammad, Dunya
    [J]. PEDIATRIC CLINICS OF NORTH AMERICA, 2022, 69 (06) : 1115 - 1129
  • [23] VESICOURETERAL REFLUX AND REFLUX NEPHROPATHY
    SENEKJIAN, HO
    SUKI, WN
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 1982, 2 (05) : 245 - 250
  • [24] VESICOURETERAL REFLUX AND REFLUX NEPHROPATHY
    BAILEY, RR
    [J]. KIDNEY INTERNATIONAL, 1991, 39 (02) : 360 - 360
  • [25] VESICOURETERAL REFLUX AND REFLUX NEPHROPATHY
    THOMSEN, HS
    [J]. ACTA RADIOLOGICA-DIAGNOSIS, 1985, 26 (01): : 3 - 13
  • [26] Vesicoureteral Reflux and Reflux Nephropathy
    Mattoo, Tej K.
    [J]. ADVANCES IN CHRONIC KIDNEY DISEASE, 2011, 18 (05) : 348 - 354
  • [27] Mikrophthalmus, Kolobome und vesikoureteraler Reflux
    [J]. Monatsschrift Kinderheilkunde, 2005, 153 : 286 - 290
  • [28] Pediatric vesicoureteral reflux guidelines panel summary report on the management of primary vesicoureteral reflux in children
    Elder, JS
    Peters, CA
    Arant, BS
    Ewalt, DH
    Hawtrey, CE
    Hurwitz, RS
    Parrott, TS
    Snyder, HM
    Weiss, RA
    Woolf, SH
    Hasselblad, V
    [J]. JOURNAL OF UROLOGY, 1997, 157 (05): : 1846 - 1851
  • [29] Recent advances in the understanding and management of primary vesicoureteral reflux and reflux nephropathy
    Kamil, ES
    [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2000, 9 (02): : 139 - 142
  • [30] Vesicoureteral reflux
    Belman, AB
    [J]. PEDIATRIC CLINICS OF NORTH AMERICA, 1997, 44 (05) : 1171 - &